Literature DB >> 34304141

Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.

Anton Johansson1, Mohamed S Mohamed1, Thiago C Moulin1, Helgi B Schiöth2.   

Abstract

Several neurological symptoms and complications have been described in association with COVID-19, such as anosmia, ageusia, encephalitis and Guillain-Barré syndrome. Here, we review the literature describing SARS-CoV-2-induced neurological manifestations and provide a comprehensive discussion of proposed mechanisms underlying the neurological pathophysiology. First, we analyse the neuroinvasiveness potential of the coronavirus family based on previous SARS-CoV-1 studies. Then, we describe the current evidence on COVID-19-induced nervous tissue damage, including processes behind brain vasculopathy and cytokine storm. We also discuss in detail anosmia and Guillain-Barré syndrome. Finally, we provide a summarised timeline of the main findings in the field. Future perspectives are presented, and suggestions of further investigations to clarify how SARS-COV-2 can affect the CNS.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anosmia; COVID-19; Cytokine storm; Encephalitis; Guillain-Barré syndrome

Year:  2021        PMID: 34304141     DOI: 10.1016/j.jneuroim.2021.577658

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.

Authors:  Federico Verde; Ilaria Milone; Ilaria Bulgarelli; Silvia Peverelli; Claudia Colombrita; Alessio Maranzano; Narghes Calcagno; Nicola Ticozzi; Giovanni Battista Perego; Gianfranco Parati; Erminio Torresani; Antonia Ratti; Vincenzo Silani
Journal:  J Neurol       Date:  2022-07-04       Impact factor: 6.682

Review 2.  Acute to Chronic Electro-Clinical Manifestations of Neuro-COVID and the Long-Haul Consequences in People With Epilepsy: A Review.

Authors:  Anna Milan; Philippe Salles; Carolina Pelayo; Reinaldo Uribe-San-Martin
Journal:  Cureus       Date:  2022-06-16

Review 3.  Inflammatory reflex disruption in COVID-19.

Authors:  Khalil Hajiasgharzadeh; Mahdi Jafarlou; Behzad Mansoori; Narges Dastmalchi; Behzad Baradaran; Alireza Khabbazi
Journal:  Clin Exp Neuroimmunol       Date:  2022-04-29

4.  COVID-19-Associated Encephalopathy-Case Series and Clinical Considerations.

Authors:  Jakub Udzik; Paweł Jakubowski; Małgorzata Niekrasz; Adrian Barczyszyn; Miłosz Parczewski
Journal:  J Clin Med       Date:  2022-02-13       Impact factor: 4.241

Review 5.  Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features.

Authors:  Mohamed S Mohamed; Anton Johansson; Jörgen Jonsson; Helgi B Schiöth
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

6.  Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.

Authors:  Gema M Olivarria; Yuting Cheng; Susana Furman; Collin Pachow; Lindsay A Hohsfield; Charlene Smith-Geater; Ricardo Miramontes; Jie Wu; Mara S Burns; Kate I Tsourmas; Jennifer Stocksdale; Cynthia Manlapaz; William H Yong; John Teijaro; Robert Edwards; Kim N Green; Leslie M Thompson; Thomas E Lane
Journal:  bioRxiv       Date:  2021-11-17

7.  Occurrence of Guillain-Barre Syndrome During the Initial Symptomatic Phase of COVID-19 Disease: Coincidence or Consequence?

Authors:  Rui Seixas; David Campoamor; João Lopes; Teresa Bernardo; Hipólito Nzwalo; Dulce Pascoalinho
Journal:  Cureus       Date:  2021-11-17

8.  Neurological Manifestations and Outcomes in a Retrospective Cohort of Mexican Inpatients with SARS-CoV-2 Pneumonia: Design of a Risk Profile.

Authors:  Silvia García; Francisco Manuel Cuatepotzo-Burgos; Christian Gabriel Toledo-Lozano; Adriana Balderrama-Soto; Sofía Lizeth Alcaraz-Estrada; Luis Montiel-López; Alberto Hilarión De la Vega-Bravo; Paul Mondragón-Terán; Maribel Santosbeña-Lagunes; Maricela Escarela-Serrano; Celia Mireya Rodríguez-Martínez; María Del Carmen Méndez-Vidrio; Sandra Muñoz-López; José Alfredo Merino-Rajme; Rodrigo Alberto Rodríguez-Briseño; Fidel Cerda-Téllez; Ramón Mauricio Coral-Vázquez; Sergio Sauri-Suárez; Sandra Quiñonez-Aguilar; Juan Antonio Pineda-Juárez; Juan Antonio Suárez-Cuenca
Journal:  Healthcare (Basel)       Date:  2021-11-04

9.  Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.

Authors:  Gema M Olivarria; Yuting Cheng; Susana Furman; Collin Pachow; Lindsay A Hohsfield; Charlene Smith-Geater; Ricardo Miramontes; Jie Wu; Mara S Burns; Kate I Tsourmas; Jennifer Stocksdale; Cynthia Manlapaz; William H Yong; John Teijaro; Robert Edwards; Kim N Green; Leslie M Thompson; Thomas E Lane
Journal:  J Virol       Date:  2021-12-22       Impact factor: 5.103

Review 10.  SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability.

Authors:  Tiziana Casoli
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.